Barclays PLC Tricida, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$0.0 - $0.18 $0 - $1,609	-8,941 Reduced 92.23%	753 $0
Q4 2022 Feb 13, 2023	SELL	$0.14 - $12.49 $6,966 - $621,539	-49,763 Reduced 83.7%	9,694 $1,000
Q3 2022 Nov 03, 2022	BUY	$8.51 - $13.6 $353,241 - $564,522	41,509 Added 231.27%	59,457 $623,000
Q2 2022 Aug 12, 2022	BUY	$7.31 - $11.85 $12,215 - $19,801	1,671 Added 10.27%	17,948 $174,000
Q4 2021 Feb 14, 2022	SELL	$4.19 - $9.56 $16,659 - $38,010	-3,976 Reduced 19.63%	16,277 $156,000
Q3 2021 Nov 09, 2021	BUY	$3.56 - $4.64 $38,209 - $49,801	10,733 Added 112.74%	20,253 $94,000
Q2 2021 Aug 13, 2021	SELL	$3.95 - $5.41 $104,959 - $143,754	-26,572 Reduced 73.62%	9,520 $40,000
Q1 2021 May 13, 2021	BUY	$4.52 - $7.8 $65,756 - $113,474	14,548 Added 67.53%	36,092 $191,000
Q4 2020 Feb 11, 2021	BUY	$4.37 - $9.46 $2,962 - $6,413	678 Added 3.25%	21,544 $153,000
Q3 2020 Nov 12, 2020	SELL	$8.56 - $26.93 $421,152 - $1.32 Million	-49,200 Reduced 70.22%	20,866 $189,000
Q2 2020 Aug 12, 2020	BUY	$21.21 - $31.55 $792,935 - $1.18 Million	37,385 Added 114.39%	70,066 $1.93 Million
Q1 2020 May 13, 2020	SELL	$18.43 - $38.04 $113,197 - $233,641	-6,142 Reduced 15.82%	32,681 $718,000
Q4 2019 Feb 10, 2020	BUY	$29.6 - $43.71 $519,065 - $766,498	17,536 Added 82.38%	38,823 $1.47 Million
Q3 2019 Nov 14, 2019	BUY	$29.87 - $42.22 $154,069 - $217,770	5,158 Added 31.98%	21,287 $657,000
Q2 2019 Aug 14, 2019	BUY	$31.16 - $39.46 $274,021 - $347,011	8,794 Added 119.89%	16,129 $636,000
Q1 2019 May 15, 2019	BUY	$19.96 - $38.62 $3,173 - $6,140	159 Added 2.22%	7,335 $283,000
Q4 2018 Feb 14, 2019	BUY	$23.57 - $32.33 $21,354 - $29,290	906 Added 14.45%	7,176 $169,000
Q3 2018 Nov 14, 2018	BUY	$22.5 - $39.35 $120,825 - $211,309	5,370 Added 596.67%	6,270 $192,000
Q2 2018 Aug 14, 2018	BUY	$26.0 - $29.9 $23,400 - $26,910	900 New	900 $27,000

Others Institutions Holding TCDA

# of Institutions

Shares Held

30K

Call Options Held

124K

Put Options Held

46.5K

View Full List

About Tricida, Inc.

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

More about TCDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account